Haemostatic Factors and Ischaemic Heart Disease. The Caerphilly Study

Overview

Journal Br Heart J

Specialty Cardiology & Vascular Diseases

Date 1985 May 1

PMID 3994861

Citations 6

Authors

J W Yarnell

P M Sweetnam

P C Elwood

R Eastham

R A Gilmour

J R OBrien

M D Etherington

Affiliations

Soon will be listed here.

Abstract

In a preliminary report from the Caerphilly study four haemostatic factors showed univariate associations with prevalent ischaemic heart disease after adjusting for age. These factors were fibrinogen concentration, plasma viscosity, white cell count, and the heparin-thrombin clotting time. Age and these haemostatic variables were entered into a stepwise multiple logistic regression analysis; after age the white cell count and heparin-thrombin clotting time remained significantly associated with ischaemic heart disease. Further regression analyses indicated that diastolic blood pressure contributed additionally to this association with ischaemic heart disease but that smoking habit did not.

Citing Articles

Physiological inhibitors of blood coagulation and prothrombin fragment F 1 + 2 in type 2 diabetic patients with normoalbuminuria and incipient nephropathy.

Mormile A, Veglio M, Gruden G, Girotto M, Rossetto P, DEste P Acta Diabetol. 1996; 33(3):241-5.

PMID: 8904933 DOI: 10.1007/BF02048551.

Fibrinogen in relation to personal history of prevalent hypertension, diabetes, stroke, intermittent claudication, coronary heart disease, and family history: the Scottish Heart Health Study.

Lee A, Lowe G, Woodward M, Tunstall-Pedoe H Br Heart J. 1993; 69(4):338-42.

PMID: 8489866 PMC: 1025048. DOI: 10.1136/hrt.69.4.338.

Anticoagulant protein C activity in non-insulin-dependent diabetic patients with normoalbuminuria and microalbuminuria.

Veglio M, Gruden G, Mormile A, Girotto M, Rossetto P, DEste P Acta Diabetol. 1995; 32(2):106-9.

PMID: 7579530 DOI: 10.1007/BF00569567.

Some long term effects of smoking on the haemostatic system: a report from the Caerphilly and Speedwell Collaborative Surveys.

Yarnell J, Sweetnam P, Rogers S, Elwood P, Bainton D, Baker I J Clin Pathol. 1987; 40(8):909-13.

PMID: 3654991 PMC: 1141135. DOI: 10.1136/jcp.40.8.909.

Thrombin and plasmin activity in coronary artery disease.

Small M, Lowe G, Douglas J, Hutton I, LORIMER A, Forbes C Br Heart J. 1988; 60(3):201-3.

PMID: 2972304 PMC: 1216554. DOI: 10.1136/hrt.60.3.201.

References

Zalokar J, Richard J, Claude J . Leukocyte count, smoking, and myocardial infarction. N Engl J Med. 1981; 304(8):465-8. DOI: 10.1056/NEJM198102193040806. View

Clauss A . [Rapid physiological coagulation method in determination of fibrinogen]. Acta Haematol. 1957; 17(4):237-46. DOI: 10.1159/000205234. View

JACOB H, Hammerschmidt D . Complement-induced granulocyte aggregation. Importance in myocardial infarction and shock lung. JAMA. 1981; 245(20):2013-7. DOI: 10.1001/jama.245.20.2013. View

Baker I, Eastham R, Elwood P, Etherington M, OBrien J, Sweetnam P . Haemostatic factors associated with ischaemic heart disease in men aged 45 to 64 years. The Speedwell study. Br Heart J. 1982; 47(5):490-4. PMC: 481167. DOI: 10.1136/hrt.47.5.490. View

Thorp J, Horsfall G, STONE M . A new red-sensitive micronephelometer. Med Biol Eng. 1967; 5(1):51-6. DOI: 10.1007/BF02478842. View

Wright B, DORE C . A random-zero sphygmomanometer. Lancet. 1970; 1(7642):337-8. DOI: 10.1016/s0140-6736(70)90709-9. View

. Report of Inter-Society Commission for Heart Disease Resources. Prevention of Cardiovascular Disease. Primary prevention of the atherosclerotic diseases. Circulation. 1970; 42(6):A55-95. View

Harkness J . The viscosity of human blood plasma; its measurement in health and disease. Biorheology. 1971; 8(3):171-93. DOI: 10.3233/bir-1971-83-408. View

Friedman G, Klatsky A, SIEGELAUB A . The leukocyte count as a predictor of myocardial infarction. N Engl J Med. 1974; 290(23):1275-8. DOI: 10.1056/NEJM197406062902302. View

10.

OBrien J, Etherington M, Jamieson S, Lawford P, Sussex J, Lincoln S . Heparin neutralizing activity test in the diagnosis of acute myocardial infarction. J Clin Pathol. 1975; 28(12):975-9. PMC: 475917. DOI: 10.1136/jcp.28.12.975. View

11.

Reid D, Hamilton P, McCartney P, Rose G, Jarrett R, Keen H . Smoking and other risk factors for coronary heart-disease in British civil servants. Lancet. 1976; 2(7993):979-84. DOI: 10.1016/s0140-6736(76)90830-8. View

12.

Meade T, Chakrabarti R, Haines A, North W, Stirling Y . Characteristics affecting fibrinolytic activity and plasma fibrinogen concentrations. Br Med J. 1979; 1(6157):153-6. PMC: 1597599. DOI: 10.1136/bmj.1.6157.153. View

13.

Meade T, North W, Chakrabarti R, Stirling Y, Haines A, Thompson S . Haemostatic function and cardiovascular death: early results of a prospective study. Lancet. 1980; 1(8177):1050-4. DOI: 10.1016/s0140-6736(80)91498-1. View

14.

Prentice R, Szatrowski T, Kato H, MASON M . Leukocyte counts and cerebrovascular disease. J Chronic Dis. 1982; 35(9):703-14. DOI: 10.1016/0021-9681(82)90094-7. View

15.

Prentice R, Szatrowski T, Fujikura T, Kato H, MASON M, HAMILTON H . Leukocyte counts and coronary heart disease in a Japanese cohort. Am J Epidemiol. 1982; 116(3):496-509. DOI: 10.1093/oxfordjournals.aje.a113434. View

16.

Yarnell J, Milbank J, Walker C, Fehily A, Hayes T . Determinants of high density lipoprotein and total cholesterol in women. J Epidemiol Community Health. 1982; 36(3):167-71. PMC: 1052204. DOI: 10.1136/jech.36.3.167. View

17.

Yarnell J, Fehily A, Milbank J, Kubicki A, Eastham R, Hayes T . Determinants of plasma lipoproteins and coagulation factors in men from Caerphilly, South Wales. J Epidemiol Community Health. 1983; 37(2):137-40. PMC: 1052277. DOI: 10.1136/jech.37.2.137. View

18.

Davies M, Thomas A . Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death. N Engl J Med. 1984; 310(18):1137-40. DOI: 10.1056/NEJM198405033101801. View

19.

Heller R, Chinn S, PEDOE H, Rose G . How well can we predict coronary heart disease? Findings in the United Kingdom Heart Disease Prevention Project. Br Med J (Clin Res Ed). 1984; 288(6428):1409-11. PMC: 1441026. DOI: 10.1136/bmj.288.6428.1409. View

20.

Wilhelmsen L, Svardsudd K, Korsan-Bengtsen K, Larsson B, Welin L, Tibblin G . Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med. 1984; 311(8):501-5. DOI: 10.1056/NEJM198408233110804. View